| Literature DB >> 28852026 |
T Amuge1,2,3, D K Berger2, M S Katari4, A A Myburg5, S L Goldman4, M E Ferguson6.
Abstract
A time-course transcriptome analysis of two cassava varieties that are either resistant or susceptible to cassava brown streak disease (CBSD) was conducted using RNASeq, after graft inoculation with Ugandan cassava brown streak virus (UCBSV). From approximately 1.92 billion short reads, the largest number of differentially expressed genes (DEGs) was obtained in the resistant (Namikonga) variety at 2 days after grafting (dag) (3887 DEGs) and 5 dag (4911 DEGs). At the same time points, several defense response genes (encoding LRR-containing, NBARC-containing, pathogenesis-related, late embryogenesis abundant, selected transcription factors, chaperones, and heat shock proteins) were highly expressed in Namikonga. Also, defense-related GO terms of 'translational elongation', 'translation factor activity', 'ribosomal subunit' and 'phosphorelay signal transduction', were overrepresented in Namikonga at these time points. More reads corresponding to UCBSV sequences were recovered from the susceptible variety (Albert) (733 and 1660 read counts per million (cpm)) at 45 dag and 54 dag compared to Namikonga (10 and 117 cpm respectively). These findings suggest that Namikonga's resistance involves restriction of multiplication of UCBSV within the host. These findings can be used with other sources of evidence to identify candidate genes and biomarkers that would contribute substantially to knowledge-based resistance breeding.Entities:
Mesh:
Year: 2017 PMID: 28852026 PMCID: PMC5575035 DOI: 10.1038/s41598-017-09617-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Leaf and root symptoms of UCBSV-inoculated versus mock-inoculated Albert and Namikonga plants during the experiment. (A) Albert, UCBSV inoculated, 8 dag; (B) Albert, mock inoculated, 8 dag; (C) Namikonga, UCBSV inoculated, 8 dag; (D) Namikonga, mock inoculated, 8 dag; (E) Albert, UCBSV inoculated, 54 dag; (F) Namikonga, UCBSV inoculated, 54 dag; (G) Albert root, UCBSV inoculated, 3 mag; (H) Namikonga root, UCBSV inoculated, 3 mag; (I) Albert root, UCBSV inoculated, 12 mag; (J) Namikonga root, UCBSV inoculated, 12 mag.
Figure 2Diagnostic RT-PCR for UCBSV in the inoculum source NDL06/132, Albert and Namikonga plants at 3 mag. RNA from cassava plants from the UCBSV-inoculation experiment were amplified using the UCBSV diagnostic primers CBSDDF2/CBSDDR[54], and the RT-PCR products were separated by agarose gel electrophoresis (2%). Lanes 1–3: UCBSV inoculum source (variety NDL06/132); lanes 4–6: Albert, mock grafted with virus-negative scions of NLD06/132; lanes 7–9: Albert, UCBSV inoculated; lanes 10–12: Namikonga, mock grafted with virus-negative scions of NLD06/132; lanes 13–15: Namikonga, UCBSV inoculated and M: 1 Kb+ ladder.
Figure 3Number of UCBSV reads per million RNAseq reads retrieved from unmapped RNAseq reads of UCBSV inoculated (I) and control (C) samples from Albert (A) and Namikonga (N) varieties. In both varieties, UCBSV reads were only detected at 45 dag and 54 dag.
Total statistics for RNAseq reads from cassava varieties Albert and Namikonga sampled at eight time points after mock or graft inoculation with UCBSV.
| Time point | Mapping to cassava genome | Albert UCBSV inoculated | Albert Mock inoculated | Namikonga UCBSV inoculated | Namikonga Mock inoculated |
|---|---|---|---|---|---|
| Time zero | Mapped | — | 4,218,021,147 | — | 3,996,224,040 |
| Unmapped | — | 835,908,591 | — | 929,195,862 | |
| 6 hag | Mapped | 1,974,374,444 | 2,311,923,325 | 1,739,750,996 | 2,034,621,580 |
| Unmapped | 465,562,984 | 558,691,687 | 373,228,177 | 416,264,064 | |
| 1 dag | Mapped | 1,782,476,393 | 1,606,541,112 | 1,751,611,492 | 1,415,764,268 |
| Unmapped | 469,842,785 | 281,839,135 | 380,522,348 | 892,832,192 | |
| 2 dag | Mapped | 2,311,174,776 | 2,258,285,184 | 2,278,828,029 | 2,195,695,847 |
| Unmapped | 425,576,288 | 411,150,949 | 494,433,874 | 648,333,549 | |
| 5 dag | Mapped | 1,152,362,044 | 900,243,552 | 2,223,072,359 | 1,809,373,734 |
| Unmapped | 900,243,552 | 988,890,194 | 402,279,032 | 713,771,063 | |
| 8 dag | Mapped | 1,845,319,525 | 1,948,946,548 | 2,265,995,556 | 1,756,458,519 |
| Unmapped | 352,441,534 | 373,483,677 | 493,741,019 | 547,890,775 | |
| 45 dag | Mapped | 1,701,360,044 | 1,258,543,240 | 2,269,455,275 | 2,155,716,341 |
| Unmapped | 365,911,422 | 831,147,304 | 505,056,145 | 476,811,865 | |
| 54 dag | Mapped | 2,089,595,204 | 2,396,067,557 | 2,288,557,815 | 2,309,206,949 |
| Unmapped | 473,446,221 | 497,723,310 | 545,859,978 | 657,106,782 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
The time points were time zero (before graft inoculation), 6 hag, 1 dag, 2 dag, 5 dag, 8 dag, 45 dag and 54 dag. The figures reflect the number of RNAseq reads that mapped or did not map (unmapped) to the cassava reference genome v4.1[42].
Figure 4Number of DEGs between UCBSV-inoculated and mock-inoculated cassava varieties Albert and Namikonga at 6 hag, 1 dag, 2 dag, 5 dag, 8 dag, 45 dag and 54 dag. The DEGs were identified using the DESeq method[45].
Figure 5Over-represented GO terms for up-regulated genes in Namikonga at 2 dag and 5 dag. A = Over-represented GO terms of the category “biological process” in the Namikonga up-regulated genes at 5 dag; B = Over-represented GO terms of the category “molecular function” in the Namikonga up-regulated genes at 5 dag; C = Over-represented GO terms of the category “cellular component” in the Namikonga up-regulated genes at 5 dag; D = Over-represented GO terms of the category “biological process” in the Namikonga up-regulated genes at 2 dag; E = Over-represented GO terms of the category “molecular function” in the Namikonga up-regulated genes at 2 dag. Results are presented for over-represented GO terms with adjusted p-values in the 95% confidence interval.
GO term over-representation analysis of the up-regulated genes of Namikonga at 2 dag and 5 dag.
| GO ID | Enriched GO terms found within the up-regulated genes of Namikonga at 2 dag | No. of DEGs | Adj. p-value |
|---|---|---|---|
|
| |||
| GO:0043623 | Cellular protein complex assembly | 10 | 2.00E-02 |
| GO:0006152 | Purine nucleoside catabolic process | 10 | 5.E-03 |
| GO:1901136 | Carbohydrate derivative catabolic process | 12 | 2.E-02 |
| GO:1901565 | Organonitrogen compound catabolic process | 14 | 1.E-02 |
|
|
|
|
|
| GO:0006457 | Protein folding | 26 | 5.E-03 |
| GO:0044710 | Single-organism metabolic process | 250 | 1.E-02 |
| GO:0008152 | Metabolic process | 622 | 1.E-02 |
|
| |||
| GO:0016491 | Oxidoreductase activity | 161 | 3.E-02 |
| GO:0003824 | Catalytic activity | 667 | 9.E-04 |
|
| |||
|
| |||
|
|
|
|
|
|
|
|
|
|
| GO:0006457 | Protein folding | 27 | 3.E-02 |
| GO:0006412 | Translation | 205 | 3.E-68 |
| GO:0034645 | Cellular macromolecule biosynthetic process | 238 | 1.E-59 |
| GO:0009059 | Macromolecule biosynthetic process | 241 | 5.E-56 |
| GO:0044249 | Cellular biosynthetic process | 288 | 3.E-43 |
| GO:1901576 | Organic substance biosynthetic process | 292 | 1.E-42 |
| GO:0009058 | Biosynthetic process | 309 | 5.E-40 |
| GO:0044267 | Cellular protein metabolic process | 329 | 2.E-15 |
| GO:0019538 | Protein metabolic process | 370 | 1.E-10 |
| GO:0044260 | Cellular macromolecule metabolic process | 414 | 4.E-15 |
| GO:0043170 | Macromolecule metabolic process | 447 | 3.E-11 |
| GO:0044237 | Cellular metabolic process | 541 | 4.E-18 |
| GO:0044238 | Primary metabolic process | 582 | 2.E-10 |
| GO:0071704 | Organic substance metabolic process | 609 | 3.E-11 |
| GO:0009987 | Cellular process | 688 | 6.E-13 |
| GO:0008152 | Metabolic process | 786 | 1.E-04 |
|
| |||
|
|
|
|
|
|
|
|
|
|
| GO:0003924 | Gtpase activity | 23 | 5.E-03 |
| GO:0003723 | RNA binding | 86 | 4.E-12 |
| GO:0003735 | Structural constituent of ribosome | 202 | 3.E-78 |
| GO:0005198 | Structural molecule activity | 206 | 3.E-73 |
|
| |||
| GO:0042719 | Mitochondrial intermembrane space protein transporter complex | 5 | 3.E-02 |
| GO:0015934 | Large ribosomal subunit | 9 | 4.E-03 |
|
|
|
|
|
| GO:0005840 | Ribosome | 195 | 4.E-63 |
| GO:0043228 | Non-membrane-bounded organelle | 198 | 9.E-56 |
| GO:0030529 | Ribonucleoprotein complex | 206 | 3.E-64 |
| GO:0005622 | Intracellular | 219 | 3.E-19 |
| GO:0044444 | Cytoplasmic part | 249 | 1.E-47 |
| GO:0032991 | Macromolecular complex | 251 | 9.E-28 |
| GO:0043226 | Organelle | 255 | 2.E-21 |
| GO:0044424 | Intracellular part | 340 | 2.E-14 |
| GO:0044464 | Cell part | 416 | 9.E-09 |
Comparison of UCBSV-induced genes corresponding to the over-represented GO terms ‘translational elongation’, ‘translation factor activity, nucleic acid binding’, and ‘ribosomal subunit’ at 2 and 5 dag in Namikonga and Albert.
| Gene ID | Gene annotation | 2 dag | 5 dag | ||
|---|---|---|---|---|---|
| Albert | Namikonga | Albert | Namikonga | ||
| Log 2 FC (Adj.Pv) | Log 2 FC (Adj.Pv) | Log 2 FC (Adj.Pv) | Log 2 FC (Adj.Pv) | ||
|
| |||||
| Cassava4.1_015319 m.g | Translation elongation factor EF1B/ribosomal protein S6 family protein | 0.0(1) | −0.7(1.3E-01) | 0.2(1) | 0.6(6.8E-02) |
| Cassava4.1_010349 m.g | Translation elongation factor Ts (EF-Ts), putative | −0.4(1) | −0.5(5.7E-01) | 0.5(1) | 1.0(1.3E-02) |
| Cassava4.1_018059 m.g | Eukaryotic elongation factor 5A-1 | 0.0(1) | 0.5(3.1E-01) | −0.9(1) | 0.9(6.0E-04) |
| Cassava4.1_018052 m.g | Eukaryotic elongation factor 5A-1 | −0.2(1) | 0.2(8.1E-01) | −0.1(1) | 0.9(5.5E-03) |
| Cassava4.1_007378 m.g | GTP binding Elongation factor Tu family protein | −0.2(1) | 0.6(3.1E-01) | −0.3(1) | 1.7(4.5E-05) |
| Cassava4.1_011934 m.g | Ribosomal protein L10 family protein | −0.1(1) | −0.2(8.7E-01) | −0.4(1) | 0.8(7.5E-03) |
| Cassava4.1_019599 m.g | 60 S acidic ribosomal protein family | 0.0(1) | −0.5(4.4E-01) | −0.6(1) | 1.9(6.7E-10) |
| Cassava4.1_019305 m.g | 60 S acidic ribosomal protein family | 0.0(1) | −0.1(1.0E + 00) | −0.7(1) | 0.9(3.7E-03) |
| Cassava4.1_020132 m.g | 60 S acidic ribosomal protein family | 0.1(1) | −0.2(8.2E-01) | −0.9(1) | 0.7(1.5E-02) |
| Cassava4.1_019568 m.g | 60 S acidic ribosomal protein family | −0.1(1) | −0.2(8.9E-01) | 0(1) | 0.6(4.4E-02) |
| Cassava4.1_019588 m.g | 60 S acidic ribosomal protein family | 0.0(1) | −0.1(9.4E-01) | −0.5(1) | 0.8(4.2E-03) |
| Cassava4.1_018344 m.g | 60 S acidic ribosomal protein family | 0.0(1) | 0.2(7.2E-01) | −0.7(1) | 1.0(5.3E-04) |
|
| |||||
| Cassava4.1_016620 m.g | Eukaryotic initiation factor 4E protein | 0.2(1) | −0.2(8.6E-01) | 0.4(1) | 0.7(2.0E-02) |
| Cassava4.1_013223 m.g | Eukaryotic translation initiation factor 4E | 0.1(1) | −0.2(9.1E-01) | 0.4(1) | 0.6(6.2E-02) |
| Cassava4.1_004498 m.g | Eukaryotic translation initiation factor 3 subunit 7 (eIF3) | −0.1(1) | −0.4(5.0E-01) | 0.1(1) | 0.8(1.0E-02) |
| Cassava4.1_033528 m.g | Eukaryotic initiation factor 3 gamma subunit family protein | −0.1(1) | 0.9(5.8E-01) | 1.7(1) | 1.6(9.2E-02) |
| Cassava4.1_011050 m.g | Eukaryotic translation initiation factor 2 subunit 1 | 0.0(1) | −0.5(3.2E-01) | −0.6(1) | 0.7(2.4E-02) |
| Cassava4.1_017333 m.g | Eukaryotic initiation factor 3 gamma subunit family protein | −0.2(1) | 0.7(3.1E-01) | 0.8(1) | 1.5(1.0E-03) |
| Cassava4.1_018052 m.g | Eukaryotic elongation factor 5A-1 | −0.2(1) | 0.2(8.1E-01) | −0.1(1) | 0.9(5.5E-03) |
| Cassava4.1_018059 m.g | Eukaryotic elongation factor 5A-1 | 0.0(1) | 0.5(3.1E-01) | −0.9(1) | 0.9(6.0E-04) |
| Cassava4.1_001203 m.g | Eukaryotic translation initiation factor 3 C | −0.2(1) | −0.5(3.2E-01) | 0.3(1) | 1.5(2.0E-07) |
| Cassava4.1_020990 m.g | Eukaryotic release factor 1–3 | −0.1(1) | −0.4(5.7E-01) | −0.2(1) | 0.6(7.8E-02) |
| Cassava4.1_002530 m.g | Translation initiation factor 3B1 | 0.1(1) | −0.1(9.7E-01) | −0.3(1) | 0.8(1.3E-02) |
| Cassava4.1_002467 m.g | Translation initiation factor 2, small GTP-binding protein | 0.0(1) | −0.3(7.4E-01) | 0.6(1) | 0.6(1.1E-01) |
| Cassava4.1_015319 m.g | Translation elongation factor EF1B/ribosomal protein S6 family protein | 0.0(1) | −0.7(1.3E-01) | 0.2(1) | 0.6(6.8E-02) |
| Cassava4.1_007596 m.g | Translation initiation factor IF2/IF5 | −0.1(1) | 0.1(9.9E-01) | −0.4(1) | 0.7(1.5E-02) |
| Cassava4.1_007700 m.g | Translation initiation factor IF2/IF5 | 0.1(1) | −0.6(1.7E-01) | −0.1(1) | 0.6(4.3E-02) |
| Cassava4.1_010349 m.g | Translation elongation factor Ts (EF-Ts), putative | −0.4(1) | −0.5(5.7E-01) | 0.5(1) | 1.0(1.3E-02) |
| Cassava4.1_007378 m.g | GTP binding Elongation factor Tu family protein | −0.2(1) | 0.6(3.1E-01) | −0.3(1) | 1.7(4.5E-05) |
| Cassava4.1_018593 m.g | Nucleic acid-binding, OB-fold-like protein | 0.2(1) | −0.6(3.0E-01) | 0(1) | 0.9(5.1E-02) |
| Cassava4.1_005116 m.g | Peptide chain release factor 2 | −0.1(1) | 1.2(4.5E-01) | 1.6(1) | 2.0(8.2E-04) |
|
| |||||
| Cassava4.1_018516 m.g | Translation protein SH3-like family protein | −0.1(1) | −0.2(8.7E-01) | −0.5(1) | 0.5(9.9E-02) |
| Cassava4.1_016258 m.g | Ribosomal protein 5B | −0.2(1) | −0.4(4.7E-01) | 0.2(1) | 1.0(2.2E-04) |
| Cassava4.1_013486 m.g | Ribosomal protein l18e/L15 superfamily protein | −0.1(1) | 0.5(4.8E-01) | −0.2(1) | 0.8(8.6E-02) |
| Cassava4.1_015972 m.g | Ribosomal protein l1p/L10e family | −0.2(1) | 0.3(6.2E-01) | −0.4(1) | 1.1(7.9E-05) |
| Cassava4.1_015937 m.g | Ribosomal protein l1p/L10e family | −0.1(1) | −0.1(9.8E-01) | 0.1(1) | 0.8(3.6E-03) |
| Cassava4.1_009639 m.g | Ribosomal protein l1p/L10e family | 0.3(1) | 0.4(7.4E-01) | 0.4(1) | 2.0(9.5E-08) |
| Cassava4.1_009636 m.g | Ribosomal protein l1p/L10e family | 0.4(1) | 0.0(1.0E + 00) | 0.3(1) | 1.5(9.8E-05) |
| Cassava4.1_008473 m.g | Ribosomal protein l1p/L10e family | −0.1(1) | −0.8(8.2E-02) | 0.4(1) | 0.7(3.6E-02) |
| Cassava4.1_017425 m.g | Ribosomal protein l22p/L17e family protein | −0.2(1) | −0.2(8.3E-01) | −0.5(1) | 1.1(8.8E-05) |
| Cassava4.1_019192 m.g | Ribosomal protein l22p/L17e family protein | 0.0(1) | −0.4(5.2E-01) | −0.4(1) | 1.2(2.0E-05) |
| Cassava4.1_012305 m.g | 40 s ribosomal protein SA | −0.3(1) | −0.1(1.0E + 00) | 1.1(1) | 1.8(7.2E-08) |
| Cassava4.1_012175 m.g | 40 s ribosomal protein SA | −0.3(1) | −0.2(8.8E-01) | 0.6(1) | 1.0(2.4E-03) |
| Cassava4.1_012280 m.g | 40 s ribosomal protein SA | −0.3(1) | 0.0(1.0E + 00) | 1.7(1) | 1.3(6.4E-04) |
Comparison of UCBSV-induced genes corresponding to the over-represented GO terms ‘phosphorelay signal transduction system’ and ‘response regulator activity’ at 2 and 5 dag in Namikonga and Albert.
| Gene ID | Gene annotation | 2 dag | 5 dag | ||
|---|---|---|---|---|---|
| Albert | Namikonga | Albert | Namikonga | ||
| Log 2 FC (Adj.Pv) | Log 2 FC (Adj.Pv) | Log 2 FC (Adj.Pv) | Log 2 FC (Adj.Pv) | ||
|
| |||||
| Cassava4.1_000395 m.g | Histidine kinase 2 | 0.1(1) | 1.3(6.2E-04) | −0.9(1) | 2.1(8.6E-14) |
| Cassava4.1_000859 m.g | CHASE domain containing histidine kinase protein | 0.1(1) | 2.6(3.3E-06) | −0.3(1) | 2.1(1.6E-11) |
| Cassava4.1_001670 m.g | Histidine kinase 2 | 0.8(1) | 4.7(1.6E-36) | 0.1(1) | 2.3(3.7E-18) |
| Cassava4.1_002119 m.g | Pseudo-response regulator 7 | 0.3(1) | 1.8(1.0E-07) | −0.1(1) | 0.8(3.8E-03) |
| Cassava4.1_002915 m.g | Response regulator 12 | 0.6(1) | 1.5(1.7E-05) | 0.1(1) | 2.4(1.1E-10) |
| Cassava4.1_015446 m.g | Response regulator 9 | 0.8(1) | 4.6(1.3E-04) | −1.5(1) | 3.5(1.4E-14) |
| Cassava4.1_015815 m.g | Response regulator 9 | −0.2(1) | 4.0(6.9E-24) | −1.5(1) | 1.8(2.3E-01) |
| Cassava4.1_018229 m.g | Histidine-containing phosphotransmitter 1 | 0.4(1) | 1.0(3.0E-01) | −0.5(1) | 1.4(4.1E-07) |
| Cassava4.1_018306 m.g | Histidine-containing phosphotransmitter 1 | −0.4(1) | 3.2(7.0E-07) | 0.8(1) | −1.1(5.0E-01) |
| Cassava4.1_022288 m.g | Response regulator 9 | 0.9(1) | 4.1(1.6E-01) | 0.3(1) | 2.5(8.7E-08) |
| Cassava4.1_022850 m.g | Pseudo-response regulator 7 | 0.2(1) | 4.4(1.0E-14) | −0.5(1) | 2.5(4.5E-08) |
| Cassava4.1_024410 m.g | Histidine kinase 5 | −0.2(1) | 3.8(1.9E-02) | 2.6(1) | 0.1(1.0E + 00) |
| Cassava4.1_025220 m.g | Pseudo-response regulator 3 | 0.7(1) | 4.3(2.5E-16) | −0.5(1) | 1.2(1.7E-03) |
| Cassava4.1_026975 m.g | Response regulator 3 | 0.4(1) | 4.1(3.0E-03) | 0.0(1) | 3.5(1.3E-12) |
| Cassava4.1_033332 m.g | Pseudo-response regulator 9 | 0.4(1) | 1.3(5.6E-04) | −0.7(1) | 1.0(2.9E-04) |
| Cassava4.1_002375 m.g | Signal transduction histidine kinase, hybrid-type, ethylene sensor | −0.6(1) | −2.6(4.8E-06) | −0.2(1) | 0.8(1.2E-02) |
| Cassava4.1_015797 m.g | Response regulator 5 | −0.4(1) | 1.5(5.0E-01) | −1.3(1) | 1.3(1.6E-02) |
| Cassava4.1_023472 m.g | Response regulator 3 | −0.7(1) | 0.2(9.4E-01) | 0.6(1) | 1.4(3.8E-03) |
| Cassava4.1_027609 m.g | Response regulator 9 | 0.7(1) | 0.2(9.6E-01) | −0.4(1) | 1.8(2.3E-07) |
| Cassava4.1_027924 m.g | Signal transduction histidine kinase, hybrid-type, ethylene sensor | 0.1(1) | 0.2(8.3E-01) | 0.8(1) | 0.8(5.2E-02) |
| Cassava4.1_028820 m.g | Response regulator 2 | 0.2(1) | 1.4(8.4E-02) | −0.2(1) | 1.4(4.8E-02) |
Figure 6Selected DEGs that were expressed at significantly different levels in susceptible (Albert) and resistant (Namikonga) varieties at different time points (RNAseq data). Gene families include A and B = Leucine-rich repeat (LRR)-containing proteins, C and D = NBARC-containing proteins, E and F = Pathogenesis-related (PR) proteins, G and H = Late embryogenesis abundant (LEA) proteins, I and J = WRKY DNA, K and L = Heat shock proteins, M and N = Chaperones and O and P = Transcription factors.
Figure 7Model of cassava responses to UCBSV based on transcriptomics. DEGs = differentially expressed genes; avg = average; dag = days after grafting and mag = months after grafting.